A Trial to Evaluate the Safety and Efficacy of oNKord® in Subjects With Acute Myeloid Leukemia
Clinical trial NCT04632316 · UNKNOWN
Trial details
- NCT number
- NCT04632316
- Sponsor
- Glycostem Therapeutics BV
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-08
- Primary completion
- 2023-04-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.